Abbott Laboratories Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 304 trades in Abbott Laboratories (NYSE: ABT) since 2012, across 70 members, worth an estimated $5.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 165 buys against 138 sells, a modestly buy-led skew, with Democratic members responsible for 57% of the trades and Republican members 43%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most ABT transactions among those shown, with 23. Other recent filers include Richard Dean Dr McCormick, Mike Kelly, and Richard W. Allen. One notable disclosed move was a purchase by Rohit Khanna on May 15, 2026, up 37.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Abbott Laboratories (ABT) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Abbott Laboratories congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Jul 30, 2026 | 15 days | SELL |  $1,001 - $15,000 | +9.96% | Self | ||
 Mike Kelly House | Aug 12, 2026 | Jul 17, 2026 | 26 days | SELL | $1,001 - $15,000 | +15.35% | Spouse | |
 Richard W. Allen House | Aug 18, 2026 | Jul 14, 2026 | 35 days | SELL | $15,001 - $50,000 | +31.47% | Spouse | |
 Rick Larsen House | Jul 12, 2026 | Jul 8, 2026 | 4 days | SELL | $1,001 - $15,000 | +22.01% | Self | |
 Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | BUY | $1,001 - $15,000 | +27.98% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 23, 2026 | 13 days | SELL | $1,001 - $15,000 | +28.28% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 23, 2026 | 13 days | SELL | $1,001 - $15,000 | +28.28% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 23, 2026 | 13 days | SELL | $1,001 - $15,000 | +28.28% | Spouse | |
 Gilbert Cisneros House | Jul 2, 2026 | Jun 16, 2026 | 16 days | BUY | $1,001 - $15,000 | +28.15% | Self | |
| Jul 9, 2026 | Jun 12, 2026 | 27 days | BUY | $1,001 - $15,000 | +31.70% | Self |
Abbott Laboratories (ABT) congressional trading FAQ
Can members of Congress legally trade Abbott Laboratories (ABT) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Abbott Laboratories (ABT) trades public?
Yes. Every congressional trade in Abbott Laboratories (ABT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Abbott Laboratories (ABT)?
Members of Congress have disclosed 304 trades in Abbott Laboratories (ABT) worth $5.1M across 70 members, according to public STOCK Act filings.
Which members of Congress have traded Abbott Laboratories (ABT)?
Recent and active filers of Abbott Laboratories (ABT) disclosures include Rohit Khanna, Richard Dean Dr McCormick, Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Abbott Laboratories (ABT) more?
Across disclosed Abbott Laboratories (ABT) trades, 57% were by Democrats and 43% by Republicans, led by Democrats (57%).
What is the most recent congressional Abbott Laboratories (ABT) trade?
The most recent disclosed Abbott Laboratories (ABT) trade was a sale by Richard W. Allen, filed Aug 17, 2026.
Browse all stocks Congress tradesCongressional trading overviewAbbott Laboratories (ABT) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.